Your browser is no longer supported. Please, upgrade your browser.
Settings
SPPI Spectrum Pharmaceuticals, Inc. daily Stock Chart
SPPI [NASD]
Spectrum Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.65 Insider Own1.00% Shs Outstand67.32M Perf Week1.45%
Market Cap472.59M Forward P/E- EPS next Y-1.09 Insider Trans0.00% Shs Float59.44M Perf Month0.72%
Income-42.40M PEG- EPS next Q-0.25 Inst Own83.20% Short Float34.89% Perf Quarter4.15%
Sales183.50M P/S2.58 EPS this Y30.40% Inst Trans5.85% Short Ratio21.29 Perf Half Y11.25%
Book/sh3.57 P/B1.97 EPS next Y-21.10% ROA-8.80% Target Price9.00 Perf Year-12.47%
Cash/sh2.16 P/C3.25 EPS next 5Y- ROE-17.40% 52W Range5.45 - 8.50 Perf YTD1.30%
Dividend- P/FCF14.23 EPS past 5Y-8.60% ROI-9.60% 52W High-14.94% Beta1.53
Dividend %- Quick Ratio2.20 Sales past 5Y37.50% Gross Margin84.90% 52W Low32.66% ATR0.34
Employees241 Current Ratio2.30 Sales Q/Q-4.10% Oper. Margin-15.00% RSI (14)51.86 Volatility4.36% 5.06%
OptionableYes Debt/Eq0.42 EPS Q/Q33.30% Profit Margin-23.10% Rel Volume1.13 Prev Close7.02
ShortableYes LT Debt/Eq0.42 EarningsAug 06 AMC Payout- Avg Volume973.97K Price7.23
Recom2.20 SMA200.96% SMA501.89% SMA2007.27% Volume205,296 Change2.99%
Aug-07-15Reiterated RBC Capital Mkts Outperform $12 → $13
Apr-02-15Initiated FBR Capital Outperform $9
Feb-23-15Downgrade ROTH Capital Buy → Neutral $15 → $7
Jul-15-14Upgrade R. F. Lafferty Sell → Neutral $7.50
Oct-07-13Initiated HC Wainwright Buy $15
May-29-13Initiated Burrill Institutional Research Mkt Outperform $12
Mar-13-13Reiterated RBC Capital Mkts Outperform $19 → $16
Mar-13-13Downgrade WallachBeth Buy → Sell $20 → $5.50
May-02-11Reiterated MLV Capital Buy $12.50 → $20.50
Mar-25-11Initiated RBC Capital Mkts Outperform $12
Dec-07-10Reiterated Morgan Joseph Buy $8 → $10
Jan-12-10Upgrade Morgan Joseph Hold → Buy $8
Oct-14-09Reiterated Rodman & Renshaw Mkt Outperform $10 → $8
Sep-08-09Downgrade Morgan Joseph Buy → Hold
Sep-09-08Initiated Morgan Joseph Buy $5
Apr-23-08Downgrade Oppenheimer Outperform → Perform
Mar-18-08Downgrade Brean Murray Buy → Hold
Nov-01-07Reiterated Friedman Billings Mkt Perform $5.50 → $4
Oct-31-07Reiterated Rodman & Renshaw Mkt Outperform $8 → $6
Oct-09-07Upgrade Brean Murray Hold → Buy $11
Sep-02-15 07:00AM  Spectrum Pharmaceuticals Announces Publication of Pivotal EVOMELA (melphalan hydrochloride) for Injection Data in the Biology of Blood and Marrow Transplantation Journal Business Wire
Aug-18-15 01:04PM  SPECTRUM PHARMACEUTICALS INC Financials
Aug-17-15 07:00AM  Spectrum Pharmaceuticals Announces Agreement with FDA on the Special Protocol Assessment (SPA) for the Upcoming Apaziquone Phase 3 Trial in Patients with Non-Muscle Invasive Bladder Cancer (NMIBC) Business Wire
Aug-09-15 08:13PM  10-Q for Spectrum Pharmaceuticals, Inc. at Company Spotlight
Aug-07-15 07:06PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report +7.16%
09:23AM  Edited Transcript of SPPI earnings conference call or presentation 6-Aug-15 8:30pm GMT
Aug-06-15 05:15PM  Spectrum Pharma reports 2Q loss
04:30PM  Spectrum Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today
04:04PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:00PM  Spectrum Pharmaceuticals Reports Second Quarter 2015 Financial Results and Pipeline Update Business Wire
07:07AM  Q2 2015 Spectrum Pharmaceuticals Inc Earnings Release - Time Not Supplied
Aug-04-15 07:00AM  Biotech Pharma with Approaching FDA Decision Catalyst Accesswire
Jul-30-15 07:00AM  Spectrum Pharmaceuticals Announces Second Quarter 2015 Financial Results Teleconference and Webcast Business Wire
Jul-02-15 04:34PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-27-15 02:34AM  Edited Transcript of SPPI presentation 3-Jun-15 2:00pm GMT
Jun-24-15 07:00AM  Spectrum Pharmaceuticals Announces Publication of Beleodaq┬« Data Selected as a Rapid Communication in the Journal of Clinical Oncology Business Wire
Jun-12-15 06:15AM  Edited Transcript of SPPI earnings conference call or presentation 7-May-15 8:30pm GMT
Jun-04-15 01:44PM  Armistice Capital Raising the Stakes Against Spectrum Pharmaceuticals, Inc. (SPPI) In Its First Activist Campaign at Insider Monkey
May-29-15 02:20PM  Wall Street expects these health-care stocks to rise up to 55% at MarketWatch
07:00AM  Spectrum Pharmaceuticals Highlights Five Abstracts of Clinical Data at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, May 29-June 2, 2015 Business Wire
May-28-15 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies Global Healthcare Conference in New York City on June 3rd Business Wire
May-15-15 10:54PM  13Ds: Perry Ellis Irks Legion, Spectrum Pharma Baffles Armistice at Barrons.com
May-14-15 07:00AM  Spectrum Pharmaceuticals Commits to Review Shareholder Proposal Business Wire
May-13-15 08:51AM  Spectrum Pharmaceuticals (SPPI) in Focus: Stock Up 10.1% - Tale of the Tape
May-12-15 03:46PM  Spectrum Pharmaceuticals Up 10% On Activist's Letter +10.07%
May-11-15 08:12PM  10-Q for Spectrum Pharmaceuticals, Inc. at Company Spotlight +6.69%
May-08-15 05:36PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
May-07-15 05:37PM  Spectrum Pharma reports 1Q loss
04:02PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:00PM  Spectrum Pharmaceuticals Reports Continued Advancement of Robust, Late-Stage Pipeline and First Quarter 2015 Financial Results Business Wire
07:07AM  Q1 2015 Spectrum Pharmaceuticals Inc Earnings Release - Time Not Supplied
May-04-15 08:12PM  10-K for Spectrum Pharmaceuticals, Inc. at Company Spotlight
Apr-30-15 07:22AM  Spectrum Pharmaceuticals Announces First Quarter 2015 Financial Results Teleconference and Webcast at noodls
07:00AM  Spectrum Pharmaceuticals Announces First Quarter 2015 Financial Results Teleconference and Webcast Business Wire
Apr-08-15 04:04PM  The 52-Week Low Club for Wednesday at 24/7 Wall St.
Apr-03-15 05:32AM  Spectrum Pharma May Be a Two-Blockbuster Stock at Barrons.com
Apr-02-15 05:47AM  Coverage initiated on Spectrum Pharma by FBR Capital
Mar-30-15 07:07AM  Spectrum Pharmaceuticals Presents New Data on EVOMELATM (CE-Melphalan), at the Annual Meeting of the American Pharmacists Association (APhA) in San Diego, Highlighting Stability at noodls
07:00AM  Spectrum Pharmaceuticals Presents New Data on EVOMELATM (CE-Melphalan), at the Annual Meeting of the American Pharmacists Association (APhA) in San Diego, Highlighting Stability Business Wire
Mar-25-15 05:20PM  Ligand Pharmaceuticals: Biotech's Jack Of All Trades at Investor's Business Daily
Mar-13-15 10:03AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
07:18AM  Spectrum Pharma reports 4Q loss
07:14AM  Spectrum Pharmaceuticals Reports Robust Clinical Data and Strong 2014 Financial Results at noodls
07:07AM  Q4 2014 Spectrum Pharmaceuticals Inc Earnings Release - Time Not Supplied
07:00AM  Spectrum Pharmaceuticals Reports Robust Clinical Data and Strong 2014 Financial Results Business Wire
Mar-11-15 07:22AM  Four Oncology Key Opinion Leaders to Present at Spectrum Pharmaceuticals' Analyst Day on Friday, March 13th at noodls
07:00AM  Four Oncology Key Opinion Leaders to Present at Spectrum Pharmaceuticals Analyst Day on Friday, March 13th Business Wire
Mar-10-15 05:21PM  Spectrum Pharmaceuticals' CE-melphalan Under Review - Analyst Blog
Mar-09-15 07:11AM  Spectrum Pharmaceuticals Announces FDA's Acceptance of NDA Filing for Captisol-Enabled (Propylene Glycol-Free) Melphalan at noodls
07:00AM  Spectrum Pharmaceuticals Announces FDA's Acceptance of NDA Filing for Captisol-Enabled (Propylene Glycol-Free) Melphalan Business Wire
Mar-04-15 09:59AM  Spectrum Pharmaceuticals In-Licenses Poziotinib, a Novel pan-HER Inhibitor With Clinical Activity in Several Solid Tumors, From Hanmi Pharmaceuticals at noodls
07:00AM  Spectrum Pharmaceuticals In-Licenses Poziotinib, a Novel pan-HER Inhibitor With Clinical Activity in Several Solid Tumors, From Hanmi Pharmaceuticals Business Wire
Feb-24-15 06:02PM  Nasdaq stocks posting largest percentage decreases AP
Feb-23-15 04:04PM  The 52-Week Low Club for Monday at 24/7 Wall St. -15.82%
10:36AM  Spectrum Pharmaceuticals (SPPI) Stock Plunges to One-Year Low on Court's Fusilev Patent Ruling at TheStreet
06:02AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
Feb-20-15 05:12PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the 2015 RBC Capital Markets' Global Healthcare Conference on February 24th Business Wire
Feb-17-15 07:00AM  Spectrum Pharmaceuticals Announces Fourth Quarter 2014 Financial Results and Analyst Day Business Wire
Feb-12-15 07:00AM  Spectrum Pharmaceuticals Highlights Clinical Data for Captisol-Enabled (Propylene Glycol-Free) Melphalan at the 2015 BMT Tandem Meeting Business Wire
Feb-06-15 09:54AM  Will Ligand Pharmaceuticals (LGND) Miss on Earnings in Q4? - Analyst Blog Zacks
Feb-04-15 06:47AM  Bulls returning to Spectrum Pharma optionMONSTER
Dec-26-14 09:44AM  Spectrum submits blood-cancer drug for FDA approval at MarketWatch
07:00AM  Spectrum Pharmaceuticals Files a New Drug Application with the FDA for Captisol-Enabled (Propylene Glycol-Free) Melphalan Business Wire
Dec-10-14 05:34PM  Market's most shorted stocks CNBC
Dec-05-14 07:00AM  Spectrum Pharmaceuticals Highlights 11 Abstracts at the 56th Annual Meeting of the American Society of Hematology (ASH) in San Francisco, California, December 6-9, 2014 Business Wire
Nov-14-14 06:00AM  Biotech Stock Mailbag: Spectrum, Intercept, Orexigen, Amarin, MannKind at TheStreet
Nov-12-14 07:09PM  10-Q for Spectrum Pharmaceuticals, Inc. Company Spotlight
07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2014 Global London Healthcare Conference on November 19th Business Wire
Nov-10-14 05:07PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-07-14 05:04AM  Spectrum Pharma posts 3Q loss AP
Nov-06-14 04:30PM  Spectrum Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:18PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
04:05PM  Spectrum Pharmaceuticals Reports Strong Product Sales for the Third Quarter 2014; Sales of $47.9 Million up 15.6% Over Last Year Business Wire
07:07AM  Q3 2014 Spectrum Pharmaceuticals Inc Earnings Release - After Market Close CCBN
Oct-30-14 07:00AM  Spectrum Pharmaceuticals Announces Third Quarter 2014 Financial Results Teleconference and Webcast Business Wire
Sep-19-14 04:15PM  Spectrum Pharmaceuticals Out-Licenses Products in China Zacks
Sep-18-14 01:35PM  5 Breakout Stocks Under $10 Set to Soar Higher at TheStreet
07:00AM  Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs PR Newswire
07:00AM  Spectrum Pharmaceuticals Out-Licenses Rights for Greater China to CASI Pharmaceuticals for Three of Its Drugs Business Wire
Sep-17-14 12:01AM  Eminem Publishers Sue N.Z. Party: Intellectual Property at Bloomberg
Sep-16-14 07:00AM  Spectrum Pharmaceuticals Announces Issue of a New Patent for Beleodaq (belinostat) for Injection with Patent Term Adjustment till 2027 Business Wire
Sep-12-14 08:59AM  5 Stocks Under $10 Soaring Higher at TheStreet
Sep-10-14 04:20PM  Spectrum Pharmaceuticals to Advance Neutropenia Drug Zacks
Sep-09-14 07:00AM  Spectrum Pharmaceuticals Makes Decision to Advance SPI-2012, a Novel Long-Acting GCSF, to Phase 3 Due to Positive Phase 2 Results in its Collaboration Program with Hanmi Pharm. Co. Business Wire
Sep-02-14 02:53PM  [video] Spectrum CEO: Fusilev Sales Healthy, 'Blockbuster' Announcement Soon at TheStreet
07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Morgan Stanley Global Healthcare Conference in New York City on September 9th Business Wire
Aug-18-14 07:47AM  Why Spectrum Fell on Beleodaq Approval but Will Rocket on Melphalan Approval at TheStreet
Aug-12-14 10:30AM  Spectrum Pharmaceuticals (SPPI) Posts Strong Earnings in Q2 Zacks
Aug-08-14 05:12PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online +5.94%
09:31AM  H.C. Wainwright & Co. Sees Significant Upside Ahead For Spectrum Pharmaceuticals Benzinga
Aug-07-14 04:30PM  Spectrum Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:21PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
04:00PM  Spectrum Pharmaceuticals Reports 45% Sales Growth in the Second Quarter, Launches Fifth Product and Moves Closer to a Decision on a Potential Blockbuster Business Wire
07:07AM  Q2 2014 Spectrum Pharmaceuticals Inc Earnings Release - After Market Close CCBN
Aug-05-14 01:48PM  These eight health-care stocks could rise up to 75% at MarketWatch
Jul-31-14 07:00AM  Spectrum Pharmaceuticals Announces Second Quarter 2014 Financial Results Teleconference and Webcast Business Wire
Jul-09-14 04:31PM  Spectrum Pharmaceuticals: Key Drug Fusilev May Face Generic Competition Soon at Seeking Alpha
Jul-07-14 05:01PM  A Bad Day for Spectrum Pharmaceuticals' Good News at Motley Fool
03:00PM  Spectrum Pharmaceuticals Gains U.S. Approval of Beleodaq Zacks
Spectrum Pharmaceuticals, Inc., a biotechnology company, develops and commercializes oncology and hematology drug products. The company markets five drug products, including FUSILEV for the treatment of patients with metastatic colorectal cancer, rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL); ZEVALIN injection for patients with follicular non-Hodgkin's lymphoma; MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation of the anticancer drug vincristine for the treatment of adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; and BELEODAQ injection for patients with relapsed or refractory PTCL. It is also developing Captisol-enabled MELPHALAN, an intravenous formulation for clinicians and patients in the multiple myeloma transplant setting; APAZIQUONE to treat non-muscle invasive bladder cancer; and SPI-2012 for the treatment of chemotherapy-induced neutropenia. The company sells its drugs through a direct sales force in the United States; and through distributors in Europe and Japan. It has licensing and development agreement with Cell Therapeutics, Inc.; license agreement with Merck & Cie AG and Cydex Pharmaceuticals, Inc.; development and commercialization collaboration agreement with Allergan, Inc.; collaboration agreement with Nippon Kayaku Co., Ltd.; licensing and collaboration agreement with TopoTarget A/S; and co-development and commercialization agreement with Hanmi Pharmaceutical Company. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHROTRIYA RAJESH C MDChairman & CEODec 15Option Exercise5.5536,061199,9981,749,460Dec 16 07:49 PM
MAIDA ANTHONY E IIIDirectorDec 15Option Exercise6.6620,000133,20046,611Dec 16 07:35 PM
Krassner Stuart MitchellDirectorOct 09Option Exercise5.8010,00058,00038,125Oct 14 04:20 PM